# The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder

> **NCT00418184** · PHASE2 · COMPLETED · sponsor: **Enzymotec** · enrollment: 200 (actual)

## Conditions studied

- Attention Deficit/Hyperactivity Disorder (ADHD)

## Interventions

- **DIETARY_SUPPLEMENT:** Phosphatidylserine-Omega3
- **OTHER:** Colored cellulose tainted with fishy odor

## Key facts

- **NCT ID:** NCT00418184
- **Lead sponsor:** Enzymotec
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-11
- **Final completion:** 2009-11
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418184, "The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00418184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*